Skip to main content
. 2018 Mar 15;13(T-NANO 2014 Abstracts):35–38. doi: 10.2147/IJN.S124703

Table 2.

Pharmacokinetic parameters

Parameters Result
Group 1 (AGM suspension) Group 2 (marketed formulation) Group 3 (AGM–NLC)
Cmax (µg/mL) 0.35±0.2 0.43±0.13 0.58±0.2
Tmax (hour) 1.5 1.5 2.25
AUC0→t (µg*h/mL) 633±0.2 772±0.29 4,357±0.24

Note: Data presented as mean ± SD.

Abbreviations: AGM, agomelatine; NLC, nanostructured lipid carrier.